Additional information
1356839-89-8(free base)
White powder
NA
ACI-121112
(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[[[(5S)-5-[[(1S)-1-carboxy-3-phenylpropyl]amino]-6-[(2S)-2-carboxypyrrolidin-1-yl]-6-oxohexyl]amino]carbonyl]-3-phenylpropyl]amino]hexanoyl] pyrrolidine-2-carboxylic acid trifluoro acetic acid (lisinopril dimer),
(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[[[(5S)-5-[[(1S)-1-carboxy-3-phenylpropyl]amino]-6-[(2S)-2-carboxypyrrolidin-1-yl]-6-oxohexyl]amino]carbonyl]-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid trifluoro acetic acid
82.2-84.3°C
C42H60N6O9.C2HF3O2
906.98
Ambient
2-8°C
(S)-Lisinopril Dimer trifluoro acetic acid ; (2S)-1-[(2S)-6-Amino-2-[[(2S)-1-[[[(5S)-5-[[(1S)-1-carboxy-3-phenylpropyl]amino]-6-[(2S)-2-carboxypyrrolidin-1-yl]-6-oxohexyl]amino]carbonyl]-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic Acid trifluoro acetic acid ;
Angiotensin-converting enzyme (ACE) inhibitors
![sec-BUTYL PACLITAXEL (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-α-hydroxy-β-[[(2S)-2-methyl-1-oxobutyl]amino]benzenepropanoate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)
